Gruenenthal Gmbh

Solvias Ag

Recordati Ireland Limited

Grunenthal Gmbh

Recordati Industria Chimica E Farmaceutica S.p.a.

Markus Von Raumer

Martin Szelagiewicz

Michael Gruss

Wolfgang Hell

Joerg Berghausen

Fritz Blatter

Amedeo Leonardi

Gianni Motta

Andreas Fischer

Susan Margaret De Paul

Jörg Berghausen

Markus Kegel

Susan Margaret Paul

A crystalline salt of 3-[2-(dimethylamino)methyl(cyclohex-1-yl)]phenol and hydrogen chloride, preferably in a 1:1 composition, including various crystalline forms of this salt, processes for preparing the various crystalline forms of this salt, pharmaceutical compositions containing the various crystalline forms of this salt, and the use of this salt as a pharmacologically active agent in a pharmaceutical composition to treat or inhibit pain or other disorders or disease states.

HCI polymorphs of 3-((2-(dimethylamino)methyl(cyclohex-1-yl)) phenol

A process for the detection of polymorphic or pseudopolymorphic forms of solid, molecular and crystallizing compounds, or of molecular, cocrystalline compounds or of solid solutions which consist of at least two solid, molecular and crystallizing compounds, in a series investigation using an apparatus for parallel investigations in vessels of an array under different conditions in each vessel, in which substantially only the amorphous form of the crystallizing compound, a solvate of the crystallizing compound or substantially only the amorphous form or a solvate of a compound in a mixture of at least two compounds is used as a suspension or solution, the solutions of amorphous compound having, at the same temperature, a higher content of crystallizable compounds than is achievable with a corresponding crystalline compound.

Process for the parallel detection of crystalline forms of molecular solids

Novel 3-[2-(dimethylamino)methyl-(cyclohex-1-yl)]-phenol maleate compounds corresponding to formula I and processes for preparing these compounds are provided. Pharmaceutical compositions including these compounds and methods of treating or alleviating pain with these compounds are also provided.

Salt of dimethylaminomethyl-phenyl-cyclohexane and crystalline forms thereof

The present invention relates to new addition salts of lercanidipine comprising lercanidipine and an acid counterion wherein the acid counterion is selected from the group consisting of: (i) inorganic acids, (ii) sulfonic acids, (iii) monocarboxylic acids, (iv) dicarboxylic acids, (v) tricarboxylic acids, and (vi) aromatic sulfonimides, with the proviso that said acid counterion is not hydrochloric acid.

Lercanidipine salts

Growing community of inventors

Arlesheim, Switzerland

Markus Von Raumer